A Study of RO7890597 in Healthy Adult Volunteers
Part of paid clinical trials in Lenexa, Kansas.
- Sponsor
- Genentech, Inc.
- Study ID
- NCT07797478
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Healthy Volunteers
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- RO7890597 — DRUGParticipants will receive RO7890597 as per the schedule described in the protocol.
- Placebo — DRUGParticipants will receive matching placebo as per the schedule described in the protocol.
- Rabeprazole — DRUGParticipants will receive rabeprazole as per the schedule described in the protocol.
- Itraconazole — DRUGParticipants will receive itraconazole as per the schedule described in the protocol.
Study Details
This study will evaluate the safety, pharmacokinetics (PK), and activity of single and multiple doses of RO7890597 compared with placebo in healthy volunteers. The study includes single ascending dose (SAD) stage, multiple ascending dose (MAD) stage, food-effect and proton pump inhibitor (PPI) stages, and a supplemental drug-drug interaction (DDI) stage.
Key Dates
- First listed
- Sep 1, 2026
- Start date
- Aug 28, 2026
- Status verified
- Aug 2026
- Primary completion
- Jun 8, 2027
- Completion
- Jun 8, 2027
Study Design
- Enrollment
- 139 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: RO7890597Participants will receive a single or multiple doses of RO7890597 alone, or with rabeprazole or itraconazole.
- Experimental: PlaceboParticipants will receive single or multiple doses of matching placebo.
Primary Outcome Measure
Incidence and Severity of Adverse Events (AEs) [ Time Frame: Up to approximately 12 weeks ]
Central Contacts
- Reference Study ID Number: GA46708 https://forpatients.roche.com/ No attachments to email below.888-662-6728 (U.S. and Canada)
- Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| ICON (LPRA) - Lenexa | Lenexa | Kansas | 66219 | - |
Find similar trials in Lenexa, KS
By research site
Related Studies
- A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell DiseasePHASE1/PHASE2 · Recruiting · Bristol-Myers Squibb · Birmingham, Alabama
- A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult ParticipantsPHASE1 · Recruiting · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Anaheim, California
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family MembersEnrolling By Invitation · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland